International Conference on Rheumatology and Autoantibody Studies
(ICRAAS-26)

22nd November 2026 || Coimbatore - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Rheumatology and Autoantibody Studies (ICRAAS), scheduled to be held on 22nd November 2026 in Coimbatore, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Rheumatology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Autoantibody Research
    This track will explore the latest findings in autoantibody research, focusing on their role in the pathogenesis of rheumatic diseases. Participants will discuss novel biomarkers and their implications for early diagnosis and treatment strategies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Molecular Diagnostics in Rheumatology
    This session will highlight cutting-edge molecular diagnostic techniques that enhance the understanding of rheumatic diseases. Emphasis will be placed on the integration of these technologies into clinical practice for improved patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Translational Research in Autoimmunity
    This track will address the challenges and successes of translating basic research findings into clinical applications in rheumatology. Discussions will focus on bridging the gap between laboratory discoveries and patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Innovative Therapeutic Strategies
    Participants will examine novel therapeutic approaches for managing rheumatic diseases, including biologics and small molecules. The session aims to evaluate the efficacy and safety of these treatments in diverse patient populations. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 05 – Clinical Research Methodologies in Rheumatology
    This track will cover various clinical research methodologies employed in rheumatology studies, including randomized controlled trials and observational studies. The focus will be on enhancing research design to yield robust and reliable results. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 06 – Patient-Centered Care in Rheumatology
    This session will emphasize the importance of patient-centered approaches in the management of rheumatic diseases. Discussions will include strategies for improving patient engagement and adherence to treatment plans. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 07 – Laboratory Techniques in Autoantibody Testing
    This track will delve into the laboratory techniques used for the detection and characterization of autoantibodies. Participants will share best practices and innovations that enhance diagnostic accuracy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 08 – Biomarker Discovery in Rheumatic Diseases
    This session will focus on the identification and validation of biomarkers that can predict disease progression and treatment response in rheumatology. The implications of these discoveries for personalized medicine will be discussed. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 09 – Immunological Mechanisms in Rheumatology
    This track will explore the immunological mechanisms underlying rheumatic diseases, including the role of immune cells and cytokines. Participants will discuss how these insights can inform therapeutic interventions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Epidemiology of Autoimmune Disorders
    This session will examine the epidemiological trends and risk factors associated with autoimmune disorders, particularly in rheumatology. Insights gained will inform public health strategies and resource allocation. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Future Directions in Rheumatology Research
    This track will provide a platform for discussing emerging trends and future directions in rheumatology research. Participants will explore innovative approaches that hold promise for transforming the field. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228